Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models.
García-Varela L, Codesido J, Perez-Pedrosa A, Muñoz-González M, Ramos-Docampo E, Rey-Bretal D, García-Otero X, Gómez-Lado N, Turrero A, Beiroa D, Rodríguez-Perez AI, Vidal A, Fernández-Ferreiro A, Pubul V, Aguiar P. García-Varela L, et al. Among authors: garcia otero x. Int J Pharm. 2024 Mar 5;652:123795. doi: 10.1016/j.ijpharm.2024.123795. Epub 2024 Jan 13. Int J Pharm. 2024. PMID: 38224761
Antifungal Combination Eye Drops for Fungal Keratitis Treatment.
Díaz-Tomé V, Bendicho-Lavilla C, García-Otero X, Varela-Fernández R, Martín-Pastor M, Llovo-Taboada J, Alonso-Alonso P, Aguiar P, González-Barcia M, Fernández-Ferreiro A, Otero-Espinar FJ. Díaz-Tomé V, et al. Among authors: garcia otero x. Pharmaceutics. 2022 Dec 22;15(1):35. doi: 10.3390/pharmaceutics15010035. Pharmaceutics. 2022. PMID: 36678663 Free PMC article.
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.
Castro-Balado A, Bandín-Vilar E, Cuartero-Martínez A, García-Quintanilla L, Hermelo-Vidal G, García-Otero X, Rodríguez-Martínez L, Mateos J, Hernández-Blanco M, Aguiar P, Zarra-Ferro I, González-Barcia M, Mondelo-García C, Otero-Espinar FJ, Fernández-Ferreiro A. Castro-Balado A, et al. Among authors: garcia otero x. Pharmaceutics. 2022 Oct 15;14(10):2194. doi: 10.3390/pharmaceutics14102194. Pharmaceutics. 2022. PMID: 36297629 Free PMC article.
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model.
García-Otero X, Mondelo-García C, Bandín-Vilar E, Gómez-Lado N, Silva-Rodríguez J, Rey-Bretal D, Victoria Otero-Espinar M, Adan A, González-Barcia M, Aguiar P, Otero-Espinar FJ, Fernández-Ferreiro A. García-Otero X, et al. Int J Pharm. 2022 Nov 5;627:122261. doi: 10.1016/j.ijpharm.2022.122261. Epub 2022 Oct 5. Int J Pharm. 2022. PMID: 36208838 Free article.
Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery.
Varela-Fernández R, García-Otero X, Díaz-Tomé V, Regueiro U, López-López M, González-Barcia M, Isabel Lema M, Javier Otero-Espinar F. Varela-Fernández R, et al. Among authors: garcia otero x. Eur J Pharm Biopharm. 2022 Mar;172:144-156. doi: 10.1016/j.ejpb.2022.02.010. Epub 2022 Feb 17. Eur J Pharm Biopharm. 2022. PMID: 35183717 Free article.
Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model.
García-Otero X, Mondelo-García C, González F, Perez-Fernandez R, Avila L, Antúnez-López JR, González-Barcia M, Adan A, Aguiar P, Otero-Espinar FJ, Bermúdez MA, Fernández-Ferreiro A. García-Otero X, et al. Pharmaceutics. 2021 Oct 19;13(10):1737. doi: 10.3390/pharmaceutics13101737. Pharmaceutics. 2021. PMID: 34684030 Free PMC article.
Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop.
García-Otero X, Díaz-Tomé V, Varela-Fernández R, Martín-Pastor M, González-Barcia M, Blanco-Méndez J, Mondelo-García C, Bermudez MA, Gonzalez F, Aguiar P, Fernández-Ferreiro A, Otero-Espinar FJ. García-Otero X, et al. Pharmaceutics. 2021 Jan 23;13(2):149. doi: 10.3390/pharmaceutics13020149. Pharmaceutics. 2021. PMID: 33498753 Free PMC article.
Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan/TPP and Chitosan/Sulfobutylether-β-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment.
Varela-Fernández R, García-Otero X, Díaz-Tomé V, Regueiro U, López-López M, González-Barcia M, Lema MI, Otero-Espinar FJ. Varela-Fernández R, et al. Among authors: garcia otero x. ACS Appl Mater Interfaces. 2021 Jan 27;13(3):3559-3575. doi: 10.1021/acsami.0c18926. Epub 2021 Jan 11. ACS Appl Mater Interfaces. 2021. PMID: 33428398
15 results